Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone plus Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid
NCT00431119Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Oct 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of mycophenolate mofetil in Bullous Pemphigoid (BP) (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoints: Cumulative total methylprednisolone doses and Rate of remission. Started Oct 1997; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
Bullous Pemphigoid (BP)
Beyond the preview
Go deeper on NCT00431119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431119.